Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53.1K Sell
18,183
-5,395
-23% -$15.4K ﹤0.01% 2922
2025
Q4
$58.2K Buy
23,578
+3,553
+18% +$8.46K ﹤0.01% 2920
2025
Q3
$44.7K Buy
20,025
+605
+3% +$1.38K ﹤0.01% 2862
2025
Q2
$46.8K Buy
19,420
+3,469
+22% +$8.44K ﹤0.01% 2686
2025
Q1
$37.2K Sell
15,951
-1,133
-7% -$2.27K ﹤0.01% 2652
2024
Q4
$31.6K Buy
17,084
+5,798
+51% +$12.8K ﹤0.01% 2675
2024
Q3
$27.5K Buy
+11,286
New +$25.3K ﹤0.01% 2623
2024
Q2
Sell
-8
Closed -$20 3777
2024
Q1
$20 Sell
8
-530
-99% -$1.38K ﹤0.01% 3764
2023
Q4
$1.51K Buy
538
+531
+7,586% +$1.43K ﹤0.01% 3398
2023
Q3
$18 Hold
7
﹤0.01% 3429
2023
Q2
$22 Sell
7
-38
-84% -$112 ﹤0.01% 3455
2023
Q1
$127 Sell
45
-3,126
-99% -$8.18K ﹤0.01% 3332
2022
Q4
$8.5K Buy
+3,171
New +$9.24K ﹤0.01% 2417

Other funds holding ABEV

NewEdge Advisors's ABEV Position: Q1 2026 in Review

NewEdge Advisors reduced its Ambev (ABEV) stake by 23% in Q1 2026, selling an estimated $15.4K and leaving 18,183 shares worth $53.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2922.

NewEdge Advisors first reported a position in ABEV in Q4 2022 and has held it in 13 quarters since. The position peaked at $58.2K in Q4 2025. 402 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

  • NewEdge Advisors held 18,183 shares of Ambev worth $53.1K as of Q1 2026.
  • NewEdge Advisors sold 5,395 Ambev shares in Q1 2026, an estimated $15.4K.
  • Ambev made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #2922 holding.
  • NewEdge Advisors first reported a position in Ambev in Q4 2022 and has held it in 13 quarters since.
  • NewEdge Advisors's Ambev position peaked at $58.2K in Q4 2025.
  • 402 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.